BioLife Solutions, Inc. - Common Stock – Cashflow (NASDAQ:BLFS) | MetaTrader

Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Mittelzufluss aus laufender Geschäftstätigkeit 6.64 M-4.59 M-8.49 M-12.5 M8.43 M20.11 M 17.9 M Mittelzufluss aus Investitionstätigkeit -24.71 M-13.19 M-58.12 M17.84 M58.3 M-71.54 M -46.19 M Zahlungsströme aus der Finanzierungstätigkeit 102.08 M-2.78 M16.32 M10.59 M-6.78 M-10.92 M -15.83 M Freier Cashflow 6.64 M-4.59 M-8.49 M-12.5 M8.43 M10.64 M 17.73 M

Nachrichten

Casdin Kapital verkauft BioLife-Aktien im Wert von 28,1 Mio. $

BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates

Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates

ResMed (RMD) Surpasses Q3 Earnings and Revenue Estimates

Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway

4 Medical Product Stocks to Buy From a Challenging Industry

Utah Medical Gains 32% in a Year: Should You Buy the Stock?

Wall Street Analysts Think BioLife Solutions (BLFS) Could Surge 70.78%: Read This Before Placing a Bet

BioLife Solutions (BLFS): COO trennt sich von Aktien im Wert von rund 49.000 $

After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for BioLife Solutions (BLFS)

BioLife Looks Strong For Fiscal Year 2026 (NASDAQ:BLFS)

Wall Street Analysts Believe BioLife Solutions (BLFS) Could Rally 35%: Here's is How to Trade